Atlas Trials

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Clinical trial NCT01178294 · COMPLETED

Trial details

NCT number
NCT01178294
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acquired Hemophilia A
Start date
2010-11-10
Primary completion
2013-07-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.